Translate 
New gene therapy clinical trial offers hope for sickle cell disease
November 14, 2017
David Williams, MD, discusses Dana-Farber/Boston Children's new gene therapy clinical trial for sickle cell disease in a live webchat.
News
Displaying 71-72 of 72 results matching:
Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine
October 16, 2017
Two Dana-Farber/Boston Children's Cancer and Blood Disorders Center faculty members, Scott Allen Armstrong, MD, PhD, and Scott Pomeroy, MD, PhD, have been elected to the National Academy of Medicine (NAM).